Neonatal polycythemia in appropriately grown infants of hypertensive mothers

I Kurlat1, A Sola

  • 1Hospital de Pediatria Juan P. Garrahan, Buenos Aires, Argentina.

Insights

Maternal hypertension significantly increases the risk of neonatal polycythemia, even in healthy-growth infants. Routine hematocrit screening for newborns of hypertensive mothers is recommended to prevent complications.

Area of Science:

  • Neonatal Medicine
  • Perinatal Health
  • Pediatric Hematology

Background:

  • Neonatal polycythemia is common in infants born to mothers with diabetes or hypertension and intrauterine growth retardation (IUGR).
  • The independent contribution of maternal hypertension versus IUGR to neonatal polycythemia risk remains unclear.

Purpose of the Study:

  • To determine the incidence of neonatal polycythemia in at-risk populations.
  • To investigate the association between maternal hypertension and neonatal polycythemia, considering fetal growth.

Main Methods:

  • Analysis of hematocrit values from 1592 consecutive neonates.
  • Capillary hematocrit measured by heel stick within 6 hours of birth.
  • Venous blood samples for confirmation if capillary hematocrit was ≥65%.

Main Results:

  • Infants of hypertensive mothers had a 12.6-fold higher risk of polycythemia compared to the general population.
  • Maternal hypertension is a significant risk factor for neonatal polycythemia, independent of fetal growth.

Conclusions:

  • Maternal hypertension poses a substantial risk for neonatal polycythemia.
  • Routine hematocrit measurement in infants of hypertensive mothers is advised for early detection and management to prevent sequelae.

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...